CAL
EBS icon

Capital Advisors Ltd’s Emergent Biosolutions EBS Stock Holding History

Capital Advisors Ltd’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Hold
30
– – ﹤0.01% 1423
2026
Q1 		$0 Hold
30
– – ﹤0.01% 1428
2025
Q4 		$0 Hold
30
– – ﹤0.01% 1405
2025
Q3 		$0 Hold
30
– – ﹤0.01% 1404
2025
Q2 		$0 Hold
30
– – ﹤0.01% 1404
2025
Q1 		$0 Sell
30
-76
-72% -$629 ﹤0.01% 1397
2024
Q4 		$1K Hold
106
– – ﹤0.01% 1181
2024
Q3 		$1K Buy
106
+76
+253% +$691 ﹤0.01% 1180
2024
Q2 		$0 Sell
30
-1,972
-99% -$8.49K ﹤0.01% 1448
2024
Q1 		$5K Buy
+2,002
New +$4.51K ﹤0.01% 872

Other funds holding EBS

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
BWM
Baron Wealth Management Troy, Michigan $386M AUM 30.18% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MFT
Moisand Fitzgerald Tamayo Orlando, Florida $1.02B AUM 21.26% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Capital Advisors Ltd's EBS Position: Q2 2026 in Review

Capital Advisors Ltd held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 30 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Capital Advisors Ltd first reported a position in EBS in Q1 2024 and has held it in 10 quarters since. The position peaked at $5K in Q1 2024. 16 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Capital Advisors Ltd held 30 shares of Emergent Biosolutions worth $0 as of Q2 2026.
  • Capital Advisors Ltd left its Emergent Biosolutions share count unchanged in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Capital Advisors Ltd's portfolio in Q2 2026, its #1423 holding.
  • Capital Advisors Ltd first reported a position in Emergent Biosolutions in Q1 2024 and has held it in 10 quarters since.
  • Capital Advisors Ltd's Emergent Biosolutions position peaked at $5K in Q1 2024.
  • 16 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Capital Advisors Ltd's 13F filing for Q2 2026, filed 16 Jul 2026.